Skip to main content

Table 3 clinical data of patients with LPL deficiency

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

  HPND
N = 20
HTG
N = 30
HPD
N = 5
P
Age 47 ± 8 47 ± 7 23 ± 6 <0.001*
Age first onset AP 40 ± 11 - 6 ± 6 <0.001**
Episode AP number 1.75 ± 0.85 - 2.5 ± 0.6 NS
Sex (Male) 19 (95%) 27 (90%) 3 (60)% NS
Smokers 15 (75%) 19 (63%) - 0.006*
HLP AF 10 (50%) 12 (40%) 4 (80%) NS
Fibrates 13 (68%) 18 (58%) - NS
BMI 27.4 ± 3.6 29.7 ± 4.8 21.3 ± 1.6 0.01
  1. HPD: patients with LPL deficiency.
  2. *Differences between HPD and the others groups.
  3. **: Differences between HPND and HPD.